Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

In the News
Greg Scott presents industry update during JPMorgan
>> View video…

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

Shenzhen Mellow Hope to Market NCPC Hepatitis B Vaccine Internationally

publication date: Aug 13, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Shenzhen Mellow Hope Pharm Industrial Co., a subsidiary of Hard to Treat Diseases, has reached an agreement to be the sole international distributor of a Recombinant Hepatitis B vaccine manufactured by North China Pharmaceutical Group, Corporation. NCPC is a large state-owned pharmaceutical company, with a specialty in vaccines. More details...

Stock Symbol: (Pink Sheets: HTDS)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events
April 14, 2010
Guangzhou, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
Suzhou, China
June 23-24, 2010
 
Partner Events

China 2010 Pharmaceutical R&D Summit
Shanghai, China
April 5-8, 2010

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners